MCID: DFC004
MIFTS: 77

Deficiency Anemia

Categories: Blood diseases, Immune diseases, Respiratory diseases

Aliases & Classifications for Deficiency Anemia

Summaries for Deficiency Anemia

MedlinePlus : 43 If you have anemia, your blood does not carry enough oxygen to the rest of your body. The most common cause of anemia is not having enough iron. Your body needs iron to make hemoglobin. Hemoglobin is an iron-rich protein that gives the red color to blood. It carries oxygen from the lungs to the rest of the body. Anemia has three main causes: blood loss, lack of red blood cell production, and high rates of red blood cell destruction. Conditions that may lead to anemia include Heavy periods Pregnancy Ulcers Colon polyps or colon cancer Inherited disorders A diet that does not have enough iron, folic acid or vitamin B12 Blood disorders such as sickle cell anemia and thalassemia, or cancer Aplastic anemia, a condition that can be inherited or acquired G6PD deficiency, a metabolic disorder Anemia can make you feel tired, cold, dizzy, and irritable. You may be short of breath or have a headache. Your doctor will diagnose anemia with a physical exam and blood tests. Treatment depends on the kind of anemia you have. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Deficiency Anemia, also known as anemia, is related to iron-refractory iron deficiency anemia and folic acid deficiency anemia, and has symptoms including angina pectoris, edema and chest pain. An important gene associated with Deficiency Anemia is TTR (Transthyretin), and among its related pathways/superpathways are Insulin receptor recycling and JAK-STAT signaling pathway (KEGG). The drugs Warfarin and Furosemide have been mentioned in the context of this disorder. Affiliated tissues include kidney, bone and bone marrow, and related phenotypes are Reduced mammosphere formation and homeostasis/metabolism

Disease Ontology : 12 A hematopoietic system disease that is characterized by a decrease in the normal number of red blood cells.

PubMed Health : 63 About anemia: Anemia (uh-NEE-me-uh) is a condition in which your blood has a lower than normal number of red blood cells. Anemia also can occur if your red blood cells don't contain enough hemoglobin (HEE-muh-glow-bin). Hemoglobin is an iron-rich protein that gives blood its red color. This protein helps red blood cells carry oxygen from the lungs to the rest of the body. If you have anemia, your body doesn't get enough oxygen-rich blood. As a result, you may feel tired or weak. You also may have other symptoms, such as shortness of breath, dizziness, or headaches. Severe or long-lasting anemia can damage your heart, brain, and other organs in your body. Very severe anemia may even cause death.

Wikipedia : 75 Anemia (also spelled anaemia) is a decrease in the total amount of red blood cells (RBCs) or hemoglobin... more...

Related Diseases for Deficiency Anemia

Diseases related to Deficiency Anemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 2839)
# Related Disease Score Top Affiliating Genes
1 iron-refractory iron deficiency anemia 35.5 TMPRSS6 HJV EPO
2 folic acid deficiency anemia 34.7 THPO TFRC TF EPO CRP
3 hereditary spherocytosis 34.3 TFRC HFE G6PD
4 iron deficiency anemia 34.2 TMPRSS6 THPO TFRC TFR2 TF SLC40A1
5 cold agglutinin disease 34.2 IL6 CRP
6 microcytic anemia 33.7 TMPRSS6 TFRC TF SLC11A2 EPO
7 iron metabolism disease 33.4 TFRC TFR2 TF SLC40A1 SLC11A2 HJV
8 hyperferritinemia with or without cataract 33.3 TF HFE
9 hemoglobin h disease 33.2 TFRC TF HBG2 G6PD EPO
10 aceruloplasminemia 33.1 TFR2 TF HJV HFE HAMP CP
11 fetal erythroblastosis 33.0 TFRC EPO ALB
12 atransferrinemia 32.8 TFRC TFR2 TF SLC40A1 SLC11A2 HJV
13 bone marrow cancer 32.3 THPO IL6 EPOR EPO
14 thalassemia 32.3 TFRC TF HFE EPO
15 iron overload in africa 32.2 TFRC TFR2 TF SLC40A1 HFE HAMP
16 hemochromatosis, type 4 32.2 TFR2 TF SLC40A1 HJV HFE HAMP
17 hypochromic microcytic anemia 32.0 TMPRSS6 TF SLC11A2 CP
18 thrombocytosis 32.0 THPO IL6 EPO CRP
19 hemoglobinopathy 31.7 TF HFE HAMP EPO
20 beta-thalassemia 31.6 TFRC TFR2 TF HFE HBG2 G6PD
21 acquired immunodeficiency syndrome 31.5 IL6 EPO ALB
22 perinatal necrotizing enterocolitis 31.4 THPO IL6 CRP
23 sickle cell disease 31.4 HBG2 G6PD EPO
24 pyelonephritis 31.4 IL6 CRP ALB
25 hemosiderosis 31.4 TFRC TF SLC40A1 SLC11A2 HFE HAMP
26 meningitis 31.3 IL6 CRP ALB
27 polycythemia 31.3 THPO TFRC EPOR EPO
28 sickle cell anemia 31.3 HBG2 G6PD EPO
29 kwashiorkor 31.3 TTR TF ALB
30 kidney disease 31.3 TTR TF IL6 EPO CRP ALB
31 typhoid fever 31.3 IL6 CRP ALB
32 peritonitis 31.3 IL6 CRP ALB
33 alpha-thalassemia 31.3 TFRC HBG2 G6PD EPO
34 cholangitis 31.2 IL6 CRP ALB
35 arteries, anomalies of 31.2 IL6 CRP ALB
36 purpura 31.2 THPO IL6 CRP
37 trypanosomiasis 31.2 TF IL6 ALB
38 porphyria cutanea tarda 31.2 TFRC TF HFE HAMP
39 wilson disease 31.2 TF HFE CP ALB
40 peripheral vascular disease 31.2 IL6 CRP ALB
41 congenital hemolytic anemia 31.0 TF G6PD EPO
42 appendicitis 31.0 IL6 CRP ALB
43 coronary stenosis 31.0 IL6 CRP ALB
44 anemia of prematurity 31.0 HAMP EPOR EPO
45 liver cirrhosis 31.0 TTR THPO TF HFE ALB
46 gastroenteritis 31.0 IL6 CRP ALB
47 siderosis 30.9 TFRC TF SLC40A1 HFE
48 obstructive jaundice 30.9 TTR IL6 CRP ALB
49 end stage renal failure 30.9 TF IL6 EPO CRP ALB
50 hemochromatosis, type 1 30.9 TMPRSS6 TFRC TFR2 TF SLC40A1 SLC11A2

Comorbidity relations with Deficiency Anemia via Phenotypic Disease Network (PDN): (show top 50) (show all 324)


3-Hydroxyacyl-Coa Dehydrogenase Deficiency Acquired Thrombocytopenia
Active Peptic Ulcer Disease Acute Conjunctivitis
Acute Cystitis Acute Kidney Failure
Acute Leukemia Acute Maxillary Sinusitis
Acute Myocardial Infarction Acute Pancreatitis
Acute Proliferative Glomerulonephritis Acute Vascular Insufficiency of Intestine
Adjustment Disorder Adrenal Gland Disease
Agammaglobulinemia, X-Linked Alcoholic Gastritis
Alcoholic Hepatitis Alcoholic Liver Cirrhosis
Alcoholic Neuropathy Alzheimer Disease
Amyloidosis Anemia, Autoimmune Hemolytic
Anus Cancer Anxiety
Aortic Aneurysm Aortic Atherosclerosis
Aortic Valve Disease 1 Asbestosis
Ascending Colon Cancer Aspergillosis
Atrioventricular Block Atrophic Gastritis
Atypical Depressive Disorder Autonomic Nervous System Disease
Bacteremia 2 Basilar Artery Insufficiency
Benign Essential Hypertension Benign Hypertensive Renal Disease
Bladder Cancer Bleeding Disorder, Platelet-Type, 11
Blepharitis Bronchiectasis
Bronchitis Bronchopneumonia
Bullous Pemphigoid Candidiasis
Cardiac Arrest Cardiogenic Shock
Cecal Benign Neoplasm Celiac Disease 1

Graphical network of the top 20 diseases related to Deficiency Anemia:



Diseases related to Deficiency Anemia

Symptoms & Phenotypes for Deficiency Anemia

UMLS symptoms related to Deficiency Anemia:


angina pectoris, edema, chest pain

GenomeRNAi Phenotypes related to Deficiency Anemia according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.17 ALB EPOR HFE TFR2 TFRC THPO

MGI Mouse Phenotypes related to Deficiency Anemia:

46 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.39 ALB CP CRP EPO EPOR FOXP3
2 cardiovascular system MP:0005385 10.34 CP CRP EPO EPOR FOXP3 G6PD
3 hematopoietic system MP:0005397 10.33 CP EPO EPOR FOXP3 G6PD HFE
4 cellular MP:0005384 10.25 ALB CP EPO EPOR FOXP3 G6PD
5 immune system MP:0005387 10.25 CP CRP EPO EPOR FOXP3 HFE
6 growth/size/body region MP:0005378 10.22 EPOR FOXP3 G6PD HFE IL6 SLC11A2
7 liver/biliary system MP:0005370 10.13 ALB CP EPO EPOR FOXP3 HFE
8 digestive/alimentary MP:0005381 10.1 ALB FOXP3 HFE IL6 SLC40A1 TFRC
9 mortality/aging MP:0010768 10.07 ALB EPO EPOR FOXP3 G6PD HFE
10 integument MP:0010771 9.97 EPO FOXP3 HJV IL6 SLC11A2 SLC40A1
11 no phenotypic analysis MP:0003012 9.7 EPOR FOXP3 HBG2 HFE TFR2 TFRC
12 normal MP:0002873 9.56 ALB EPO EPOR FOXP3 HBG2 HFE
13 renal/urinary system MP:0005367 9.17 ALB FOXP3 HJV IL6 SLC11A2 SLC40A1

Drugs & Therapeutics for Deficiency Anemia

PubMed Health treatment related to Deficiency Anemia: 63

Treatment for anemia depends on the type, cause, and severity of the condition. Treatments may include dietary changes or supplements, medicines, procedures, or surgery to treat blood loss.

Drugs for Deficiency Anemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 965)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Warfarin Approved Phase 4 81-81-2 6691 54678486
2
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
3
Amlodipine Approved Phase 4 88150-42-9 2162
4
Doxazosin Approved Phase 4 74191-85-8 3157
5
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
6
Atenolol Approved Phase 4 29122-68-7 2249
7
Acitretin Approved Phase 4 55079-83-9, 69427-46-9 6437841
8
Leuprolide Approved, Investigational Phase 4 53714-56-0 3911 657181
9
Esmolol Approved Phase 4 103598-03-4, 81147-92-4 59768
10
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
11
Halofantrine Approved Phase 4 69756-53-2 37393
12
Artesunate Approved, Investigational Phase 4 88495-63-0 5464098 6917864
13
Copper Approved, Investigational Phase 4 7440-50-8 27099
14
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
15
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
16
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
17
Cinacalcet Approved Phase 4 226256-56-0 156419
18
Selenium Approved, Investigational, Vet_approved Phase 4 7782-49-2
19
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
20
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
21
Nitric Oxide Approved Phase 4 10102-43-9 145068
22
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
23
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
24
Metformin Approved Phase 4 657-24-9 4091 14219
25
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
26
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
27
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
28
Lumefantrine Approved Phase 4 82186-77-4 6437380
29
Artemether Approved Phase 4 71963-77-4 68911 119380
30
Ferrous gluconate Approved Phase 4 299-29-6
31
Testosterone enanthate Approved Phase 4 315-37-7 9416
32
Methyltestosterone Approved Phase 4 58-18-4 6010
33
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
34
Testosterone Approved, Experimental, Investigational Phase 4 481-30-1, 58-22-0 6013 10204
35
Piperazine Approved, Vet_approved Phase 4 110-85-0 4837
36
Nevirapine Approved Phase 4 129618-40-2 4463
37
carbamide peroxide Approved Phase 4 124-43-6
38
Mycophenolic acid Approved Phase 4 24280-93-1 446541
39
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
40
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
41
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
42
Pentazocine Approved, Vet_approved Phase 4 359-83-1 441278
43
Ranitidine Approved Phase 4 66357-35-5, 66357-59-3 3001055
44
Thiopental Approved, Vet_approved Phase 4 76-75-5 3000715
45
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
46
Ledipasvir Approved Phase 4 1256388-51-8 67505836
47
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
48
Racepinephrine Approved Phase 4 329-65-7 838
49
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
50
Abacavir Approved, Investigational Phase 4 136470-78-5 65140 441300

Interventional clinical trials:

(show top 50) (show all 4248)
# Name Status NCT ID Phase Drugs
1 The Effect of a Nutrient Fortified Oat Drink on Iron, Zinc, Vitamin A, and Vitamin C Status Among Filipino Children Unknown status NCT01418898 Phase 4
2 The Value of Iron Treatment for Postoperative Patients With Anemia: a Randomized Double Blind Controlled Trial Unknown status NCT01975272 Phase 4 Ferinject;Ferrous fumarate;Placebo for ferrous fumarate;Placebo for ferinject
3 Randomized Cross-Over Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease Unknown status NCT02774057 Phase 4 Captafer®;Iron Sulfate
4 Multicenter Randomized Open-label Controlled Study to Investigate Treatment Response of IV Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease or Gastric Bypass Unknown status NCT02086968 Phase 4 Injectafer;Ferrous Sulfate tablets
5 Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia. Unknown status NCT00199277 Phase 4 i.v. iron sucrose;Oral iron
6 Effektivität Der in Der Schwangerschaftsvorsorge routinemässig Angewandten Eisenprophylaxe Unknown status NCT02487719 Phase 4 Iron sulfate and Iron polymaltose for prevention of iron deficiency anemia
7 Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency Unknown status NCT00479102 Phase 4 Ferripel-3 - iron polysaccharide complex for prevention
8 Predictors of Response to Treatment With Iron and Erythropoietin in Dialysis Anaemia Unknown status NCT02707757 Phase 4 Iron sucrose;Erythopoietin stimulating agent
9 Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients Unknown status NCT02416778 Phase 4 Ferric carboxymaltose, Ferinject® 50mg Iron/ml Solution for Injection / Infusion
10 Different Doses of Anti-thymocyte Globin With 2.5 or 3.75mg/kg to Treat Child Severe Aplastic Anemia Unknown status NCT01997372 Phase 4 ATG
11 An Pilot Study to Assess the Efficacy of Intravenous Iron Isomaltoside 1000 (Monofer®) in the Management of Anaemia Associated With the Palliative Management of Oesophagogastric Adenocarcinoma Unknown status NCT01927328 Phase 4 Iron isomaltoside 1000
12 Effect of Mobile-Directly Observed Therapy (DOT) on Adherence to Hydroxyurea Treatment in Adult HbSS Patients at Muhimbili National Hospital (MNH) in Tanzania: a Pilot Study Unknown status NCT02844673 Phase 4 Hydroxyurea
13 The Impact of Treatment of Anaemia With Intravenous Iron on Haematological Values for Patients After Colorectal Surgery Unknown status NCT02999217 Phase 4 Iron isomaltoside;Saline
14 Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial. Unknown status NCT02242188 Phase 4 Iron
15 Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients. A Randomized, Controlled, Double-blind Study Unknown status NCT03211286 Phase 4 Tranexamic Acid;Saline Solution
16 Efficacy and Safety of Erythropoietin in the Treatment of Anemia in Patients With Lymphoma After Autologous Hematopoietic Stem Cell Transplantation Unknown status NCT03010579 Phase 4 erythropoietin;iron supplementation
17 Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function Unknown status NCT00418119 Phase 4 erythropoietin
18 Efficacy and Safety of Intravenous Iron Sucrose in Patients With Hip Fracture to Prevent Perioperative Anemia Unknown status NCT01084122 Phase 4 Iron sucrose
19 Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations. Unknown status NCT00248716 Phase 4 Ferrous gluconate and iron polysaccharide complex
20 A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant Papua New Guinean Women Unknown status NCT02575755 Phase 4 Azithromycin plus piperaquine phosphate;Sulfadoxine-pyrimethamine
21 Multi-center Clinical Study of Immunosuppressants, Cyclophosphamide, And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia Unknown status NCT02838992 Phase 4 Rabbit ATG, (Genzyme);Cy;CsA
22 Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia Unknown status NCT01995331 Phase 4 cyclophosphamide,cyclosporine A
23 Effects of Early Short-term Intravenous Iron Supplements Combinded EPO in Preterm Infants Unknown status NCT02060851 Phase 4 Iron sucrose;EPO
24 The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Unknown status NCT00247507 Phase 4 acetylcysteine
25 Cluster Randomised Trial to Compare Effectiveness of the Combined Use of Indoor Residual Spraying (IRS) and Long-lasting Insecticidal Nets (LLINs) to LLINs Alone for Malaria Prevention in Muleba District, Kagera Region, Tanzania Unknown status NCT01697852 Phase 4
26 Anemia Treatment in Inflammatory Bowel Disease: Predictive Factors of Response to Oral Iron Treatment Unknown status NCT02760940 Phase 4 oral liposomal iron
27 Randomized, Controlled Study of Iron Supplementation of Infants With Birth Weights 2000-2500 g Unknown status NCT00558454 Phase 4 Iron
28 The Effect of Intra Venus Ferric Carboxymaltose Preoperative on Hemoglobin and Blood Transfusion Post Cardiac Surgery Unknown status NCT02939794 Phase 4 Ferinject;Placebo
29 Child With Severe Aplastic Anemia (SAA) Therapy: the Injection of Umbilical Cord Derived Mesenchymal Stem Cells. Unknown status NCT02218437 Phase 4 MSC+ATG
30 Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease Unknown status NCT00204256 Phase 4 Iron sucrose
31 Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis Unknown status NCT00173706 Phase 4 L-Carnitine Injection
32 Evaluation of the Public Health Impact and Cost Effectiveness of Seasonal Intermittent Preventive Treatment in Children in Senegal Unknown status NCT00712374 Phase 4 sulfadoxine-pyrimethamine plus amodiaquine
33 Nephropathy in Type 2 Diabetes: Effects of an Intensive Multifactorial Intervention Trial on Cardio-renal Events. Unknown status NCT00535925 Phase 4 current therapy;irbesartan;ramipril;hydrochlorothiazide;furosemide;amlodipine;atenolol;doxazosin;clonidine;insulin;simvastatin;fibrate;erythropoietin;aspirin
34 The Impact of Intermittent Preventive Malaria Treatment With Artemisinin Combination Therapy (ACT) on Hemoglobin, Malaria, Schistosomiasis, and School Attention Among Primary Schoolchildren in the Kassena-Nankana Districts, Ghana Unknown status NCT01459146 Phase 4 Artemether-lumefantrine combination plus albendazole;Artemether-lumefantrine plus Praziquantel plus Albendazole;Albendazole plus Praziquantel
35 Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC Unknown status NCT01795794 Phase 4 omeprazole
36 A Multi-Center, Open-Label, Randomized, Parallel Group Study of the Efficacy and Safety of Ferrlecit in the Maintenance of Iron Stores and Serum Hemoglobin Concentration in Hemodialysis Patients Receiving Erythropoietin. Unknown status NCT00223938 Phase 4 Oral Iron;sodium ferric gluconate;sodium ferric gluconate
37 Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial Unknown status NCT00168948 Phase 4 Sulfadoxin (12.5) Pyrimethamine (250 mg)
38 Tranexamic Acid in Knee Joint Surgery - a Randomised Controlled Trial Unknown status NCT02278263 Phase 4 Tranexamic Acid;Normal saline (0.9% NaCl)
39 Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels Unknown status NCT01374776 Phase 4 Double blind, randomized, placebo controlled inter
40 A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin. Unknown status NCT02150291 Phase 4 Neurobion;placebo
41 How Many Patients Are in Need of Vitamin B12 Injections? Unknown status NCT00326833 Phase 4 vitamin B12
42 Safety of Ticagrelor Plus Warfarin Versus Clopidogrel+Aspirin+Warfarin in Patients With Persistent or Permanent Atrial Fibrillation and Undergoing PCI-S: A Randomized, Open, Controlled, Parallel Group, Multi-center Trial Unknown status NCT02206815 Phase 4 Ticagrelor+Warfarin;Clopidogrel+Aspirin+Warfarin
43 A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance Unknown status NCT00103753 Phase 4 deferiprone
44 An Open Label Trial to Show That Subjects With Severe Plaque-Type Psoriasis Receiving Acitretin 25 mg/Day And Stabilized On A Photochemotherapy Regimen Who Are Experiencing Retinoid-Related Adverse Events, Benefit From A Reduction In Acitretin Dose to 17.5 mg/Day, While Maintaining Comparable Efficacy Along With Improved Tolerability Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
45 Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease: a Randomized Clinical Trial Unknown status NCT01155128 Phase 4
46 Ulipristal Acetate Versus GnRH Analogue for Myometrial Preservation in Patients With Submucosal Uterine Leiomyoma G2 Unknown status NCT02357563 Phase 4 ulipristal acetate;Leuprolide acetate
47 Does Intraoperative Intravenous Iron Sucrose Enhance Postoperative Oxygenation Profile in Total Arthroplasty Surgery? Unknown status NCT02544828 Phase 4 Iron Sucrose 200mg;placebo
48 Efficacy and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for the Treatment of Uncomplicated Malaria in Guinea-Bissau. Unknown status NCT01704508 Phase 4 Artemether-lumefantrine;Dihydroartemisinin-piperaquine
49 Randomized and Controlled Clinical Trial of Transfusional Requirements in Patients With Acute Gastrointestinal Bleeding. Unknown status NCT00414713 Phase 4
50 Canadian Collaborative Group for the Prevention of Illness in Chronic Renal Disease. The Canadian Prevention of Renal and Cardiovascular Endpoints Trial Unknown status NCT00231803 Phase 4

Search NIH Clinical Center for Deficiency Anemia

Inferred drug relations via UMLS 72 / NDF-RT 51 :


darbepoetin alfa
Darbepoetin alfa
Epoetin Alfa
Epoetin delta
Erythropoietin
Iron
Methoxy polyethylene glycol-epoetin beta
Nandrolone
nandrolone decanoate
nandrolone phenpropionate
Oxymetholone
Sodium Ascorbate
Sodium ferric gluconate complex

Cochrane evidence based reviews: anemia

Genetic Tests for Deficiency Anemia

Genetic tests related to Deficiency Anemia:

# Genetic test Affiliating Genes
1 Anemia 29

Anatomical Context for Deficiency Anemia

MalaCards organs/tissues related to Deficiency Anemia:

41
Kidney, Bone, Bone Marrow, Heart, Myeloid, Testes, Liver

Publications for Deficiency Anemia

Articles related to Deficiency Anemia:

(show top 50) (show all 35372)
# Title Authors PMID Year
1
Immediate Transfusion in African Children with Uncomplicated Severe Anemia. 38 17
31365799 2019
2
Transfusion Volume for Children with Severe Anemia in Africa. 38 17
31365800 2019
3
Evaluation of Effect of Statins on Erythropoietin Resistance in Patients of Chronic Kidney Disease on Maintenance Haemodialysis. 17
31313547 2018
4
Ribosomal protein S19 binds to its own mRNA with reduced affinity in Diamond-Blackfan anemia. 9 38
20395159 2010
5
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. 9 38
20406921 2010
6
Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients. 9 38
20438534 2010
7
Polyarthritis and anemia in a hemodialysis patient: systemic lupus erythematosus following treatment with interferon alpha. 9 38
20353741 2010
8
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. 9 38
20196168 2010
9
The first case of a class I glucose-6-phosphate dehydrogenase deficiency, G6PD Santiago de Cuba (1339 G > A), in a Chinese population as found in a survey for G6PD deficiency in northeastern and central China. 9 38
20200584 2010
10
Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia. 9 38
20019408 2010
11
[Soluble tranferrin receptor in the biological diagnosis of iron deficiency. Report of 24 cases]. 9 38
20209848 2009
12
Hemolytic anemia after zopiclone overdose. 9 38
19821637 2009
13
[Management of anemia and bone marrow hypoplasia in the treatment of myeloid leukemia]. 9 38
19860200 2009
14
Hemochromatosis gene mutations and treatment of anemia in patients on hemodialysis. 9 38
19732172 2009
15
Serum transferrin receptors: Distribution and diagnostic performance in pre-school children. 9 38
19394251 2009
16
MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. 9 38
19591577 2009
17
[Anemia in hospitalized patients with cirrhosis: prevalence, clinical relevance and predictive factors]. 9 38
19663083 2009
18
Causes and consequences of inflammation on anemia management in hemodialysis patients. 9 38
19432697 2009
19
Role of interleukin-6 in the anemia of chronic disease. 9 38
18336871 2009
20
Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. 9 38
19265263 2009
21
Current controversies in the management of the anemia of prematurity. 9 38
19167579 2009
22
[Density-specific distribution of erythrocytes in different types of anemia]. 9 38
19253711 2009
23
[Expression of erythropoietin receptor in leukemia cells and relation of erythropoietin level with leukemic anemia]. 9 38
19099624 2008
24
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. 9 38
18815191 2008
25
The anemia of ageing is not associated with increased plasma hepcidin levels. 9 38
18676162 2008
26
The role of oxidative stress in hemolytic anemia. 9 38
18991647 2008
27
Is obesity associated with anemia of chronic disease? A population-based study. 9 38
18719644 2008
28
Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis. 9 38
18837771 2008
29
Anemia and cerebral outcomes: many questions, fewer answers. 9 38
18806052 2008
30
Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M. 9 38
18925459 2008
31
Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. 9 38
18547996 2008
32
Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia. 9 38
18758412 2008
33
Relationship between inflammatory cytokines and cardiorenal anemia syndrome: treatment with recombinant human erythropoietin (rhepo). 9 38
18923748 2008
34
Anemia in monkey collagen-induced arthritis is correlated with serum IL-6, but not TNFalpha. 9 38
18309490 2008
35
Anemia and iron status in young fertile non-professional female athletes. 9 38
18092176 2008
36
[Anemia and lung cancer]. 9 38
18589288 2008
37
[Anemia and nutritional status of children in day-care centers in Guaxupé]. 9 38
18506326 2008
38
Anemia in chronic heart failure: etiology and treatment options. 9 38
18303527 2008
39
[Anemia in patients with cancer]. 9 38
18330028 2008
40
Role of Gas6 in erythropoiesis and anemia in mice. 9 38
18188450 2008
41
[Physiopathologic aspects of anemia and thrombocytopenia in children with cancers: the roles of erythropoietin and thrombopoietin]. 9 38
18819233 2008
42
Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. 9 38
18200583 2008
43
Cross-sectional study on the prevalence of anemia among rural elderly in Asan. 9 38
20126358 2008
44
Transferrin receptor in proliferation of T lymphocytes in infants with iron deficiency. 9 38
17617082 2007
45
Anemia associated with pegylated interferon-alpha2a and alpha2b therapy in hemodialysis patients. 9 38
17598372 2007
46
Anemia correction in malignancy management: threat or opportunity? 9 38
17367848 2007
47
Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. 9 38
17218383 2007
48
Anemia in north of Iran (south-east of Caspian Sea). 9 38
19086521 2007
49
Prevalence and correlates of anemia and uncontrolled anemia in chronic hemodialysis patients--the Campania Dialysis Registry. 9 38
17520570 2007
50
Liver transplantation and anemia in familial amyloidosis ATTR V30M. 9 38
17453623 2007